This rule development will consider rules necessary to correct the language in paragraphs (1) and (2) of the rule to conform to existing laws that are incorporated by reference.

 

DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

Drugs, Devices and Cosmetics

RULE NO.:RULE TITLE:

61N-1.006Drugs and Devices; Labeling Requirements

PURPOSE AND EFFECT: This rule development will consider rules necessary to correct the language in paragraphs (1) and (2) of the rule to conform to existing laws that are incorporated by reference.

SUBJECT AREA TO BE ADDRESSED: Adoption and incorporation by reference of federal labeling requirements for prescription drugs and devices.

RULEMAKING AUTHORITY: 499.01, 499.05, F.S.

LAW IMPLEMENTED: 499.01, 499.007, F.S.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Janetta Sampson, Operations Management Consultant Manager, Division of Drugs, Devices, and Cosmetics, Department of Business and Professional Regulation; [e-mail] or [phone].

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.